CLSA Downgrades Telix Pharmaceuticals Ltd (TLX:AU) to Outperform (2)
Tweet
Share
E-mailGet Alerts AU Hot Sheet
Price: $22.06 -0.81%
Rating Summary:
7 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 42
Rating Summary:
7 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 42
Trade Now!
Join SI Premium – FREE
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
CLSA analyst Silvia Luo downgraded Telix Pharmaceuticals Ltd (TLX:AU) from Buy (1) to Outperform (2) with a price target of AUD4.30 (from AUD4.30).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Grupo Aeroportuario del Pacifico SAB de CV (GAPB:MM) (PAC) to Neutral
- Mahindra & Mahindra Financial Services Ltd. (MMFS:IN) PT Raised to INR167 at Goldman Sachs
- HDFC Bank Ltd (HDFCB:IN) (HDB) PT Raised to INR1,853 at Goldman Sachs
Create E-mail Alert Related Categories
Downgrades, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
